0001567619-18-004358.txt : 20181019
0001567619-18-004358.hdr.sgml : 20181019
20181019170625
ACCESSION NUMBER: 0001567619-18-004358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181017
FILED AS OF DATE: 20181019
DATE AS OF CHANGE: 20181019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Havey Adam
CENTRAL INDEX KEY: 0001514588
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 181130989
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20853
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2018-10-17
0
0001367644
Emergent BioSolutions Inc.
EBS
0001514588
Havey Adam
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Business Operations
Common Stock
2018-10-17
4
M
0
314
25.62
A
29567
D
Common Stock
2018-10-17
4
S
0
314
61.50
D
29253
D
Stock Options (Right to Buy)
25.62
2018-10-17
4
M
0
314
0.00
D
2021-03-10
Common Stock
314
8179
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
Consists of an option granted under the company's stock incentive plan as amended and restated.
The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
/s/ S. Scott Lieberman, Attorney-in-fact
2018-10-19